• Something wrong with this record ?

Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons

A. Petrušková, D. Guhathakurta, EY. Akdaş, B. Perelló-Amorós, R. Frischknecht, EM. Weiss, T. Páleníček, A. Fejtová

. 2025 ; 169 (3) : e70020. [pub] -

Language English Country England, Great Britain

Document type Journal Article

Grant support
Univerzita Karlova v Praze
ELAN no. P112 Medizinische Fakultät, Friedrich-Alexander-Universität Erlangen-Nürnberg
FE1335/3 Deutsche Forschungsgemeinschaft
FR2758/3 Deutsche Forschungsgemeinschaft
20-25349S Grantová Agentura České Republiky
57552336 Deutscher Akademischer Austauschdienst

The serotonergic psychedelics psilocybin, LSD and DMT hold great promise for the development of new treatments for psychiatric conditions such as major depressive disorder, addiction and end-of-life anxiety. Previous studies in both animals and humans have confirmed the effects of these drugs on neuronal activity and plasticity. However, the understanding of the mechanisms of action of these substances is limited. Here we show rapid effects of psychedelics on presynaptic properties, using live cell imaging at the level of single synapses in primary rat cortical neurons. Using the genetically encoded reporter of synaptic vesicle fusion synaptopHluorin, we detected a reduced fraction of synaptic vesicles that fused in response to mild or strong electrical stimulation 3-30 min after application of serotonergic psychedelics. These effects were transient and no longer present 24 h after treatment. While DMT only reduced the total recycling pool, LSD and psilocin also reduced the size of the readily releasable vesicle pool. Imaging with the sensors for glutamate, iGluSnFR, and presynaptic calcium, synGCaMP6, showed that while psilocin and DMT increased evoked glutamate release, LSD and psilocin reduced evoked presynaptic calcium levels. Interestingly, psilocin also affected short-term plasticity leading to a depression of responses to paired stimuli. The rapid and drug-specific modulation of glutamatergic neurotransmission described in this study may contribute to distinct anxiolytic and antidepressant properties of serotonergic psychedelics.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009618
003      
CZ-PrNML
005      
20250429134713.0
007      
ta
008      
250415s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jnc.70020 $2 doi
035    __
$a (PubMed)40022486
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Petrušková, Aneta $u Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany $u National Institute of Mental Health, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0009000071466105
245    10
$a Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons / $c A. Petrušková, D. Guhathakurta, EY. Akdaş, B. Perelló-Amorós, R. Frischknecht, EM. Weiss, T. Páleníček, A. Fejtová
520    9_
$a The serotonergic psychedelics psilocybin, LSD and DMT hold great promise for the development of new treatments for psychiatric conditions such as major depressive disorder, addiction and end-of-life anxiety. Previous studies in both animals and humans have confirmed the effects of these drugs on neuronal activity and plasticity. However, the understanding of the mechanisms of action of these substances is limited. Here we show rapid effects of psychedelics on presynaptic properties, using live cell imaging at the level of single synapses in primary rat cortical neurons. Using the genetically encoded reporter of synaptic vesicle fusion synaptopHluorin, we detected a reduced fraction of synaptic vesicles that fused in response to mild or strong electrical stimulation 3-30 min after application of serotonergic psychedelics. These effects were transient and no longer present 24 h after treatment. While DMT only reduced the total recycling pool, LSD and psilocin also reduced the size of the readily releasable vesicle pool. Imaging with the sensors for glutamate, iGluSnFR, and presynaptic calcium, synGCaMP6, showed that while psilocin and DMT increased evoked glutamate release, LSD and psilocin reduced evoked presynaptic calcium levels. Interestingly, psilocin also affected short-term plasticity leading to a depression of responses to paired stimuli. The rapid and drug-specific modulation of glutamatergic neurotransmission described in this study may contribute to distinct anxiolytic and antidepressant properties of serotonergic psychedelics.
650    _2
$a zvířata $7 D000818
650    12
$a halucinogeny $x farmakologie $7 D006213
650    _2
$a krysa rodu Rattus $7 D051381
650    12
$a kyselina glutamová $x metabolismus $7 D018698
650    12
$a mozková kůra $x účinky léků $x metabolismus $x cytologie $7 D002540
650    12
$a neurony $x účinky léků $x metabolismus $7 D009474
650    _2
$a kultivované buňky $7 D002478
650    _2
$a synaptické vezikuly $x účinky léků $x metabolismus $7 D013572
650    _2
$a LSD $x farmakologie $7 D008238
650    _2
$a psilocybin $x farmakologie $7 D011562
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a serotoninové látky $x farmakologie $7 D018490
650    _2
$a tryptaminy $x farmakologie $7 D014363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Guhathakurta, Debarpan $u Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany $1 https://orcid.org/0000000164756366
700    1_
$a Akdaş, Enes Yağız $u Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
700    1_
$a Perelló-Amorós, Bartomeu $u Department of Biology, Animal Physiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
700    1_
$a Frischknecht, Renato $u Department of Biology, Animal Physiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
700    1_
$a Weiss, Eva-Maria $u Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany $1 https://orcid.org/0009000912298557
700    1_
$a Páleníček, Tomáš $u National Institute of Mental Health, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Fejtová, Anna $u Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany $1 https://orcid.org/0000000218154409
773    0_
$w MED00002832 $t Journal of neurochemistry $x 1471-4159 $g Roč. 169, č. 3 (2025), s. e70020
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40022486 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134709 $b ABA008
999    __
$a ok $b bmc $g 2311160 $s 1246699
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 169 $c 3 $d e70020 $e - $i 1471-4159 $m Journal of neurochemistry $n J Neurochem $x MED00002832
GRA    __
$p Univerzita Karlova v Praze
GRA    __
$a ELAN no. P112 $p Medizinische Fakultät, Friedrich-Alexander-Universität Erlangen-Nürnberg
GRA    __
$a FE1335/3 $p Deutsche Forschungsgemeinschaft
GRA    __
$a FR2758/3 $p Deutsche Forschungsgemeinschaft
GRA    __
$a 20-25349S $p Grantová Agentura České Republiky
GRA    __
$a 57552336 $p Deutscher Akademischer Austauschdienst
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...